STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on hard-to-treat prostate cancer shows promise
Disease control CompletedThis study tested whether adding a precise, high-dose radiation treatment (SBRT) to the hormone therapy apalutamide helps control prostate cancer that has stopped responding to standard hormone therapy and spread to a few spots. Twenty-six men with this type of cancer took part. …
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC
-
Can a targeted drug boost hormone therapy for prostate cancer before surgery?
Disease control CompletedThis phase 2 trial tested whether adding the drug axitinib to standard hormone therapy before surgery helps control prostate cancer that has spread to nearby lymph nodes. 73 men with previously untreated prostate cancer received either hormone therapy alone or hormone therapy plu…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC